© 2019 by hemotune

  • Black Facebook Icon
  • Black Twitter Icon
  • Black LinkedIn Icon

created by wyssraumdesign


November 13, 2019

Sepsis is unquestionably one of the most fatal conditions of our time, yet even patients who survive sepsis are still very much affected by the experience;

October 22, 2019

Hemotune focuses on controlling sepsis; the intense, and often life-threatening, response of the immune system to defend against pathogens and pathogen-derived proteins in the bloodstream. Although sepsis and septic shock are quite extreme manifestations of infection, every...

October 7, 2019

In this year's Wyss Annual Event start ups within the Wyss Zurich incubator, old and new, came together to present their work and raise awareness about their technology. The Wyss Zurich is a joint accelerator of the University of Zurich and ETH Zurich (Swiss Federal Institut...

September 13, 2019

Sepsis arises from the urgency of the human body to attack infection - so much that the patient’s life is in danger. It is estimated that 30 million people are affected by sepsis annually, including 4 million newborns and children. Six million of these patients will die(1),...

August 29, 2019

It has been well documented that sepsis can happen to almost anyone and thus awareness is paramount in ensuring that appropriate and timely treatment is given. Although symptoms can vary, noticing a few signs early can prove life-saving.

Symptoms indicating the possibility of...

June 15, 2019

We recently got to introduce our magnetic blood purification system to the first Global Health Forum organized by Boao Forum for Asia in Qingdao, China. The focus of the forum was 'Health Beyond Health – In The Year of Sustainable Development 2030', bringing together healthc...

November 12, 2018

A recent article published in the Lancet highlights the rising threat to public health by antibiotic resistant bacteria. It is based on analysis of European health data from the year 2015. The study states that the burden of infection from antibiotic-resistant bacteria is si...

October 30, 2018

hemotune AG was selected for Phase I funding by the EU Horizon 2020 Small and Medium Enterprises (SME) Instrument.

The SME Instrument is part of the research and innovation program by the EU and supports groundbreaking innovative ideas for products, services or processes that...

October 5, 2018

Over the last months we have welcomed several new team members adding complementary expertise to the team. Dr. Edouard Fonck is focussing on Business Development while Dr. Ursina Haltinner is responsible for Regulatory and Quality Affairs and Max Bär is working on the Nanoso...

July 12, 2018

Learn more about sepsis and hemotune's magnetic blood purification in the article published at one oft largest Swiss newspapers Blick am Abend and on higgs.ch.

Please reload